Searchable abstracts of presentations at key conferences in endocrinology

ea0013p258 | Reproduction | SFEBES2007

The androgen receptor CAG repeat polymorphism is associated with serum testosterone levels and obesity in men with Type 2 diabetes

Stanworth Roger , Kapoor Dheeraj , Channer Kevin , Jones T. Hugh

Men with Type 2 diabetes have a high prevalence of low testosterone levels. Testosterone replacement therapy (TRT) has been shown to improve insulin sensitivity and glycaemic control in men with Type 2 diabetes. TRT also reduces fat mass and central obesity. The androgen receptor CAG repeat polymorphism length (AR CAG) correlates positively with transcriptional activity of the receptor as well as body fat, and insulin levels in healthy men. Most studies have not found an assoc...

ea0009p2 | Diabetes and metabolism | BES2005

Rosiglitazone increases testosterone levels in hypogonadal men with Type 2 diabetes

Kapoor D , Goodwin E , Channer K , Jones T

Type 2 diabetes mellitus is associated with increased incidence of low serum testosterone levels in men. Testosterone is known to be positively correlated with insulin sensitivity. Rosiglitazone is an insulin sensitizing agent that reduces insulin resistance by binding to PPAR gamma receptor. The purpose of this study was to determine the effect of Rosiglitazone on testosterone levels in hypogonadal men with Type 2 diabetes.This study was approved by BDG...

ea0009p19 | Diabetes and metabolism | BES2005

Cholesterol feeding induces fatty streak formation in the testicular feminised mouse

Nettleship J , Jones R , Channer K , Jones T

Introduction: Low endogenous testosterone is associated with atherosclerosis in elderly men. The aim of this study was to determine whether an inactive androgen receptor (AR) coupled with testosterone deficiency, inherent to the testicular feminised (Tfm) mouse, is associated with atherosclerosis following cholesterol feeding.Methods: Eight-week-old Tfm (n=34) and XY (n=32) littermate controls were fed for 16, 20, 24 or 28 weeks on either diet 1 (compris...

ea0009p33 | Diabetes and metabolism | BES2005

Testosterone does not promote A7r5 rat aortic vascular smooth muscle cell growth

Kerry K , Jones R , Channer K , Jones T

Vascular smooth muscle cells (VSMC) form a major constituent of the atherosclerotic plaque providing structural stability. However, increased cell number due to high proliferation rates can lead to greater artery occlusion. Testosterone replacement therapy improves exercise capacity and reduces symptoms of angina in men with coronary artery disease, although its effect upon VSMC growth is currently unknown. Testosterone deficiency is associated with increased atheroma burden a...

ea0009p35 | Diabetes and metabolism | BES2005

Study of the effect of testosterone upon apoptosis in the rat aortic A7r5 vascular smooth muscle cell line

Kerry K , Jones R , Channer K , Jones T

Several studies have demonstrated that atherosclerosis is associated with low serum levels of testosterone and replacement therapy reduces myocardial ischaemia in men. Vascular smooth muscle cell (VSMC) apoptosis reduces plaque stability. The role of testosterone if any, in this process is unknown. Testosterone has been demonstrated act via both the classic androgen receptor and by calcium channel antagonism. Calcium channel blockers have been shown to induce VSMC apoptosis. W...

ea0009p136 | Steroids | BES2005

Establishment of physiological and supra-physiological testosterone dosing regimen in mice

Nettleship J , Jones R , Channer K , Jones T

Objective: The aim of this study was to determine dosing regimen to replace testosterone to physiological levels in the testicular feminised (Tfm) mouse, and also to produce similar supraphysiological testosterone concentrations in Tfm and XY littermates.Methods: Eight-week-old Tfm (n=66) and XY littermate controls (n=24) received a single 10 microlitre intramuscular injection of testosterone (Sustanon 100 - 100 milligrams testosterone per litre, or Sust...

ea0009p206 | Clinical | BES2005

Thionamide resistant thyrotoxicosis - three illustrative cases

Lee S , Kapoor D , Thomas W , Jones T

Antithyroid drug (ATD) resistant thyrotoxicosis raises difficult management issues. We describe three recent cases of apparent refractory thyrotoxicosis.Case 1: A 31 year old woman presented in July 2003 with thyrotoxicosis. Despite treatment with carbimazole (CBZ) 20 milligrams tds, serum free thyroxine (FT4) concentrations remained around 60 picomoles per litre (11-20). In October, CBZ dose was increased to 40 milligrams bd and dexamethasone 2 milligra...

ea0007p17 | Comparative endocrinology | BES2004

An appraisal of biochemical assessment of hypogonadism and bio-available testosterone in adult men

Malkin C , Morris P , Channer K , Jones T

Hypogonadism is difficult to confirm with standard assays. A large proportion of testosterone (T) is bound to sex hormone binding globulin (SHBG) and is biologically inert. Accurate measures of free and biological-available-testosterone (Bio-T) are largely unavailable. In this study we compared formulae calculated from the total testosterone (TT) and SHBG in their ability to predict hypogonadism and/or Bio-T.TT and SHBG were determined by ELISA and Bio-T...

ea0007p36 | Diabetes, metabolism and cardiovascular | BES2004

A7r5 rat aortic vascular smooth muscle cell apoptosis is reduced by testosterone

Kerry K , Clark S , Jones R , Channer K , Jones T

Low testosterone levels in men are associated with increased atherosclerosis, and testosterone replacement therapy has been shown to reduce myocardial ischemia in men with coronary artery disease. Vascular smooth muscle cell (VSMC) apoptosis is proposed to reduce plaque stability, but the role of testosterone in this process is unknown. Testosterone causes vasodilatation via calcium channel antagonism and the calcium channel antagonist nifedipine induces VSMC apoptosis. We hav...

ea0007p37 | Diabetes, metabolism and cardiovascular | BES2004

Mitogen-induced apoptosis in A7r5 rat aortic vascular smooth muscle cells is not effected by testosterone

Kerry K , Clark S , Jones R , Channer K , Jones T

Atherosclerotic plaque smooth muscle cells (SMCs) are sensitive to apoptotic stimuli, increasing plaque instability. Testosterone replacement therapy is beneficial in men with coronary artery disease, although its effect upon plaque stability is unknown. We have utilised the rat A7r5 vascular SMC line to investigate the effects of testosterone on apoptosis induced by serum deprivation or the calcium channel antagonist nifedipine.Cells were plated at 1500...